Clinical Trial: A Study to Evaluate Efficacy and Safety of VX-864 in Participants With the PiZZ Genotype
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Alpha-1 Antitrypsin Deficiency
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Open-label Study Evaluating Efficacy and Safety of VX-864 in Subjects With Alpha-1 Antitrypsin Deficiency Who Have the PiZZ Genotype, Over 48 Weeks
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of VX-864 in participants with the PiZZ genotype over 48 weeks.
Read more